Literature DB >> 818335

Nonspecific complement activation by streptococcal structures. II. Properdin-independent initiation of the alternate pathway.

J W Tauber, M J Polley, J B Zabriskie.   

Abstract

Complement consumption by isolated membranes and walls from Group A streptococci and various other gram-positive microbes has been tested. These microbial structures were found to activate the alternate complement pathway. However, unlike endotoxin, inulin, or other plant polysaccharides, activation of complement by our material was found to bypass properdin. The activating factor(s) also differs from cobra venom in its/their requirement for factor D. Preliminary experiments suggest this factor isolated from membranes to be a protein and to have a mol wt greater than 40-60,000 daltons. Our studies have led us to speculate that the phylogenetic role of the alternate complement pathway may be the primordial nonspecific defense system which has retained certain fundamental aspects up to the present time.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 818335      PMCID: PMC2190200          DOI: 10.1084/jem.143.6.1352

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  27 in total

1.  IMPROVED TECHNIQUE FOR THE PREPARATION OF STREPTOCOCCAL CELL WALLS.

Authors:  A S BLEIWEIS; W W KARAKAWA; R M KRAUSE
Journal:  J Bacteriol       Date:  1964-10       Impact factor: 3.490

2.  A simple method for the isolation and purification of total lipides from animal tissues.

Authors:  J FOLCH; M LEES; G H SLOANE STANLEY
Journal:  J Biol Chem       Date:  1957-05       Impact factor: 5.157

3.  The requirement for a hydrazine-sensitive serum factor and heat-labile serum factors in the inactivation of human C'3 by zymosan.

Authors:  L PILLEMER; I H LEPOW; L BLUM
Journal:  J Immunol       Date:  1953-11       Impact factor: 5.422

4.  Properties of highly purified human properdin.

Authors:  J Ensky; C F Hinz; E W Todd; R J Wedgwood; J T Boyer; I H Lepow
Journal:  J Immunol       Date:  1968-01       Impact factor: 5.422

5.  Enteric bacteria cross-reactive with Neisseria meningitidis groups A and C and Diplococcus pneumoniae types I and 3.

Authors:  J B Robbins; L Myerowitz; J K Whisnant; M Argaman; R Schneerson; Z T Handzel; E C Gotschlich
Journal:  Infect Immun       Date:  1972-11       Impact factor: 3.441

6.  Antiphagocytic effects of staphylococcal protein A.

Authors:  J H Dossett; G Kronvall; R C Williams; P G Quie
Journal:  J Immunol       Date:  1969-12       Impact factor: 5.422

7.  The reaction of zymosan with the properdin system: isolation of purified factor D from guinea pig serum and study of its reaction characteristics.

Authors:  V Brade; A Nicholson; G D Lee; M M Mayer
Journal:  J Immunol       Date:  1974-05       Impact factor: 5.422

8.  Influence of the alternate complement pathway in opsonization of several bacterial species.

Authors:  A Forsgren; P G Quie
Journal:  Infect Immun       Date:  1974-08       Impact factor: 3.441

9.  Studies of L forms and protoplasts of group A streptococci. I. Isolation, growth, and bacteriologic characteristics.

Authors:  E H FREIMER; R M KRAUSE; M McCARTY
Journal:  J Exp Med       Date:  1959-12-01       Impact factor: 14.307

10.  The lethal effect of endotoxins on the chick embryo.

Authors:  R T SMITH; L THOMAS
Journal:  J Exp Med       Date:  1956-08-01       Impact factor: 14.307

View more
  24 in total

1.  Alternate complement pathway activation by group A streptococci: role of M-protein.

Authors:  A L Bisno
Journal:  Infect Immun       Date:  1979-12       Impact factor: 3.441

2.  Effects of pneumococcal mucopeptide and capsular polysaccharide on phagocytosis.

Authors:  R K Dhingra; R C Williams; W P Reed
Journal:  Infect Immun       Date:  1977-01       Impact factor: 3.441

3.  Chemical analysis of changes in membrane composition during growth of Streptococcus pyogenes.

Authors:  I van de Rijn; R E Kessler
Journal:  Infect Immun       Date:  1979-12       Impact factor: 3.441

4.  Complement activating factor(s) of Trypanosoma lewisi: some physiochemical characteristics of the active components.

Authors:  K Nielsen; J Sheppard; I Tizard; W Holmes
Journal:  Can J Comp Med       Date:  1978-01

5.  Modulation of complement fixation and the phlogistic capacity of group A, B, and D streptococci by human lysozyme acting on their cell walls.

Authors:  J K Spitznagel; K J Goodrum; D J Warejcka; J L Weaver; H L Miller; L Babcock
Journal:  Infect Immun       Date:  1986-06       Impact factor: 3.441

Review 6.  Biologically active products from African Trypanosomes.

Authors:  I Tizard; K H Nielsen; J R Seed; J E Hall
Journal:  Microbiol Rev       Date:  1978-12

7.  Complement activation by the alternative pathway and macrophage enzyme secretion in the pathogenesis of chronic inflammation.

Authors:  H U Schorlemmer; D Bitter-Suermann; A C Allison
Journal:  Immunology       Date:  1977-06       Impact factor: 7.397

8.  Activation of the alternative complement pathway by L-phase variants of gram-positive bacteria.

Authors:  F T Saulsbury; J A Winkelstein
Journal:  Infect Immun       Date:  1979-03       Impact factor: 3.441

9.  Effect of muralytic enzyme degradation of streptococcal cell wall on complement activation in vivo and in vitro.

Authors:  M J Janusz; R A Eisenberg; J H Schwab
Journal:  Inflammation       Date:  1987-03       Impact factor: 4.092

10.  Activation of the alternative pathway of complement in human serum by Propionibacterium acnes (Corynebacterium parvum) cell fractions.

Authors:  G F Webster; U R Nilsson; W P McArthur
Journal:  Inflammation       Date:  1981-06       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.